Quick Takeaways
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 18 Nov 2022, 19:13.
Pascal Touchon - 16 Nov 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Signature
- /s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
- Issuer symbol
- ATRA
- Transactions as of
- 16 Nov 2022
- Net transactions value
- -$70,004
- Form type
- 4
- Filing time
- 18 Nov 2022, 19:13:47 UTC
- Previous filing
- 18 Aug 2022
- Next filing
- 03 Mar 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 18 Nov 2022."
What Changed
- Previous filing in this sequence was filed on 18 Aug 2022.
- Current net transaction value: -$70,004.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATRA | Common Stock | Sale | $70,004 | -15,591 | -3.4% | $4.49 | 441,696 | 16 Nov 2022 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units. |
| F2 | The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2022 and November 17, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney